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suppressor cells (Gabrilovich et al., 2007).
In this context, a recent report (Fridlender
et al., 2009) has indicated that murine
PMNs in tumors can undergo ‘‘N1’’ or
‘‘N2’’ polarization depending on mi-
croenvironmental cues such as TGF-b,
thus mirroring at least to some extent
the diversity of macrophage activation
and echoing the findings in the present
study. Whether IL-10 represents a major
cytokine produced by PMN-like MDSC
and/or N2-type PMNs infiltrating tumors
remains to be determined. In conclusion,
these studies call for a reappraisal of
the plasticity and regulatory functions of
PMNs in immune reactions and related
pathologies.
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In this issue of Immunity, Lin et al. (2009) implicate interleukin-17 in the regulation of T helper 1 (Th1) cell
immunity against Francisella tularensis. These findings add a unique twist to the cytokine regulation of
T cell differentiation and function.The immune system has evolved to pro-
tect an organism against a wide variety
of infectious agents, including viruses,
fungi, bacteria, and multicellular para-
sites. These pathogens employ many
different strategies to survive and multiply
in the host, which can lead directly or indi-
rectly to pathology because they interfere
with homeostasis or function of affected
cells and tissues. However, the immune
system is quite adept in facing and
handling the threats imposed by these
pathogens, using an array of specialized
cells and effector mechanisms. In this
issue of Immunity, Lin et al. (2009) de-
scribe a unique way in which the immune
system uses the strengths of two T cell
subsets to eliminate the intracellular path-
ogen Francisella tularensis.
T cells play an integral part in regulation
and execution of host defense. Generally
characterized by expression of the CD4
coreceptor, helper T cells are involved in700 Immunity 31, November 20, 2009 ª2009orchestrating the activities of the immune
system. Helper T cells can be categorized
in subpopulations that each are respon-
sible for a different task in the immune
response and are in fact educated to do
so. The basis of this concept was pro-
vided by the studies of Mosmann and
Coffman (1989), who observed that helper
T cells could be classified based on the
cytokines that they were able to produce
upon activation and that the observed
cytokine patterns were directly related to
the function of the respective T cell sub-
set. Thus, T helper 1 (Th1) cells produce
interferon-g (IFN-g), interleukin-2 (IL-2),
and lymphotoxin and are involved in
cellular immunity, whereas Th2 cells
produce IL-4, IL-5, IL-10, and IL-13 and
provide help for B cells in their activation
and differentiation leading to immuno-
globulin production and humoral immune
responses. Th1 cells provide help to cyto-
toxic CD8-positive T cells and macro-Elsevier Inc.phages to kill virus-infected cells and
cells infected with intracellular pathogens.
The production of immunoglobulin under
the control of Th2 cells is one of the mech-
anisms that leads to elimination of extra-
cellular bacteria, and, through the IgE
mediated activation of mast cells, to pro-
tection against parasites. These concepts
have been refined in recent years with the
recognition of additional T cell subsets.
Regulatory T cells, either natural, induced,
or Tr1 cells, produce IL-10 and TGFb, sup-
press the activation of effector T cells, and
provide a counter-balance against uncon-
trolled and harmful T cell responses. Th9
cells may provide additional help for
mast cells through the production of IL-9.
And finally, an additional T cell subset
that produces IL-17A, IL-17F, IL-22, and
CCL20 was designated Th17 and has
been the focus of attention lately. The
cytokines that make up this subset’s
signature profile act on stromal and
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Previewsepithelial cells to induce a number of
secondary effector molecules such as
G-CSF, which stimulates the production
and mobilization of neutrophils, acute
phase proteins, chemokines, and antimi-
crobial peptides that employ various
bacteriocidal mechanisms. In mouse
models, Th17 cells provide protection
against Klebsiella pneumoniae, Citro-
bacter rodentium, Staphylococcus au-
reus, Pseudomonas aeroginosa, and
Candida albicans infections. Thus, Th17
cells seem to be involved in immunity
against certain extracellular bacteria and
fungi, but not to intracellular bacteria
such as Mycobacteria, Listeria monocyto-
genes, and Salmonella typhimurium.
Naive T cells can differentiate into any
of the distinct T cell subsets when acti-
vated in the presence of appropriate
signals and cytokines. IL-12, a heterodi-
meric cytokine composed of p35 and
p40 subunits, induces the differentiation
Th1 cells and is produced by dendritic
cells (DC). IL-12 binds to a receptor com-
plex of IL-12Rb1 and IL-12Rb2 subunits.
Oppmann et al. (2000) described that the
IL-12p40 subunit could also pair with
another cytokine protein. The complex of
this p19 protein and p40 forms the hetero-
dimeric cytokine IL-23. IL-23 binds to a
receptor complex of a unique IL-23 re-
ceptor protein (IL-23R) and IL-12Rb1
and is also produced by DC. From studies
using cytokine-specific reagents and
the analyses of IL-23p19-deficient mice,
it has become clear that IL-23, and not
IL-12, plays a major role in the pathogen-
esis of autoimmune disease models for
inflammatory bowel disease, multiple
sclerosis (EAE), rheumatoid arthritis (CIA),
and psoriasis. The mechanism by which
IL-23 is able to play such an important
role in these diseases was elucidated
when it was recognized that IL-23 is
responsible for the induction and expan-
sion of T cells producing IL-17, the Th17
cell subset (Langrish et al., 2005).
The different T cell subsets do not oper-
ate in isolation, but there is an extensive
cross-regulation between these subsets
to ensure that the appropriate T cell sub-
set is activated and eliminates the in-
vading pathogen. Identification of the
pathogen through pathogen recognition
receptors (PRR) on DC and the presence
of cytokines will generate the appropriate
conditions and signals to naive T cells to
give rise to specific immune responses.IL-23
IL-23
IL-12
IL-12
IL-12
IL-12
IL-12
IFN-γ
IFN-γ
γδ T cell
Dendritic cell
Dendritic cell
Alveolar
macrophage
Alveolar
macrophage
Th17
Th1
Th1
IL-12
IL-17
F. tularensis infection Enhancement of protective Th1 cell response
F. tularensis
Figure 1. IL-17 Supports Th1 Cell Differentiation and Bacterial Killing in F Tularensis
Infection
Early in F tularensis infection, production of IL-12 and IL-23 by DC and alveolar macrophages induces
activation of Th1, Th17, and gd T cells and secretion of IFN -g and IL-17. This IL-17 is required for develop-
ment of a protective Th1 cell response through a mechanism where IL-17 enhances the production of
IL-12 and IFN-g by DC and alveolar macrophages. IL-12 supports the development of a Th1 cell response,
whereas IFN-g enhances bacterial killing.Effector cytokines specific for one T cell
subset can influence the differentiation
and function of another either by directly
acting on the T cells or through their activ-
ities on antigen-presenting cells. For
example, IL-4 can block Th1 and Th17
cell differentiation, but support Th2 and
Th9 cell differentiation; IL-12 and IFN-g
can block Th2 and Th17 cell differentia-
tion or function; and IL-10 can inhibit the
differentiation and function of all other
subsets but support regulatory T cells.
However, a regulatory feedback loop
involving the Th17 cell cytokine IL-17A
has not been described.
The paper of Lin et al. in this issue now
provides some perspective on this. Lin
and collegues studied the host resistance
against the intracellular bacterium Franci-
sella tularensis, the causative agent for
tularemia. Conforming to the division of
labor between T cell subsets, it was known
that inmice, resistance to pulmonary infec-
tion with a F. tularensis live vaccine strain
(LVS) is dependent on IL-12-Th1 cell
responses and IFN-g production leading
to iNOS-mediated intracellular killing. As
expected, mRNA encoding IL-12p35,
IL-12p40, IFN-g, and iNOS were induced
in the lung following LVS infection, and
the relevance of this IL-12-Th1 cell cyto-
kine pathway to resistance was confirmed
using gene-targeted animals. IL-12p40-,
IL-12p35 + IL-23p19-, IL-12Rb1-, and
IFN-g-deficient mice could not control
infection, had substantially higher lung
colony-forming units (CFU) coupled with
decreased IFN-g in the lung, lower MHCImmunity 31,class II expression on CD11c+ lung cells,
and decreased production of other proin-
flammatory cytokines.
Interestingly, genes encoding IL-23p19
and IL-17 were also found to be induced
in infected lungs, and this provided a first
clue that the IL-23-Th17 cell pathway was
involved in the protective host response
as well. The presence of IL-17 was
confirmed at the protein level, and antigen
recall experiments on cells isolated from
infected lungs showed that the majority
of IL-17 production was antigen depen-
dent. In infected lungs, both conventional
T cells expressing an ab TCR, as well as
gd T cells, contributed to the production
of IL-17. Higher amounts of IL-17 were
present in lungs from IL-12p35- and
IFN-g-deficient mice, as expected from
the inhibitory effects of these cytokines
on Th17 differentiation, and this resulted
in enhanced production of IL-17 down-
stream effector molecules such as
G-CSF, MCP-1, and KC. However, in the
absence of Th1 cell immunity, the IL-17
pathway failed to confer protection
against LVS infection. This did not ex-
clude a role for IL-23-Th17 cell responses
in the resistance against F. tularensis LVS
infection because the authors went on
to show that LVS challenge of IL-23p19-,
IL-17A-, and IL-17R-deficient mice also
resulted in susceptibility to infection,
higher CFU, and death. Thus, in the
absence of IL-23-Th17 cell immunity, Th1
protection was lost. Of the Th17 cyto-
kines, IL-17 played a dominant role in this
protection because treatment of miceNovember 20, 2009 ª2009 Elsevier Inc. 701
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sulted in increased lung CFU, and IL-22-
deficient mice were resistant to infection.
Lungs from infected IL-17- and IL-17R-
deficient mice contained substantially
reduced amounts of G-CSF, neutrophil
recruitment and cellular infiltration as
could be expected, but this may not
have been the reason for the failure in
protection. Instead the authors showed
that IL-17 and IL-17R-deficient mice had
strongly reduced expression of IFN-g
and IL-12p35 mRNA indicating that IL-17
was somehow required for the generation
of a Th1 response (Figure 1). Their next
series of experiments demonstrated that
IL-17, either in the absence or presence
of LVS, could directly induce the produc-
tion of IL-12, IFN-g, IL-6, KC and MIP-1a
in bone marrow-derived DC (BMDC),
sorted lung CD11c+ cells, bone marrow-
derived macrophages (BMDM), and
freshly isolated alveolar macrophages.
Coculture experiments of BMDC with
naive OT-II transgenic T cells and OVA
peptide showed that IL-17 could induce
the polarization of these naive T cells into
IFN-g-producing Th1 cells. BMDC from
IL-12p40-, IL-17R- and IFN-g-deficient
mice could not support this effect of IL-17The Quest for CD
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In this issue of Immunity, Turtle et al
in humans, which could bring us cl
CD8+ T cells can confer protective immu-
nity toward (intracellular) pathogens and
some cancers. In order to maintain
protection, long-living memory T cells are
generated, which might persist through-
out an individual’s lifespan, probably
without the need to re-encounter antigen
(Williams and Bevan, 2007). The develop-
702 Immunity 31, November 20, 2009 ª200on T cell differentiation, indicating that it
was specific and mediated through
induction of IL-12 and IFN-g.
These results demonstrate the IL-17
can regulate IL-12-Th1 cell immunity
against an intracellular pathogen. This
now turns the attention to the early events
following infection as they set the stage
for the ensuing immune response. The
signals that give rise to IL-12 and IL-23
production by the DC will be important
for determining a protective immune re-
sponse. Are these cytokines produced
by different types of DCs?
Timing is also an important factor be-
cause the induction of IL-12 and IFN-g
by IL-17 is a rapid and early event. The
authors show that IL-17 is produced by
antigen-specific T cells and by gd T cells,
which are part of the innate immune cells.
Are the requirements for these cell types
to produce IL-17 similar or different?
And how do the IL-17-IFN-g double
producing T cells fit in? Without doubt,
future investigations will focus on these
and other aspects of the interaction
between Th17 and Th1 cell pathways.
These interactions will likely be complex
because in the absence of DC, IL-17 has
been shown to inhibit Th1 differentiation8+ Memory Stem C
ch1,2,3,*
gy and Hygiene
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fic Immunotherapy’’ and ‘‘Immune-Monitoring,’’
.tum.de
. (2009) describe the identification of a
oser to the identification of the enigm
ment of chronic disease after infection
with common viruses such as cytomega-
lovirus (CMV) or Epstein-Barr virus (EBV)
is prevented by the constitutive presence
of virus-specific CD8+ effector cells.
Similarly, CD8+ T cells are believed to
contribute to virus control in long-term
nonprogressing HIV-infected individuals.
9 Elsevier Inc.(O’Connor et al., 2009). However, this
work now opens up insights in the IL-23-
Th17 and IL-12-Th1 pathways and shows
that there is not only counter-regulation
but also interdependence.
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distinct CD8+memory T cell subset
atic ‘‘memory stem cell.’’
How exactly CD8+ T cells are maintained
beyond the contraction phase of an
immune response is still only poorly
understood. With the identification of
functionally and phenotypically distinct
subsets of memory T cells (Sallusto
et al., 1999), however, a division of labor
in between different cell types has
